A detailed history of Virtus Fund Advisers, LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Virtus Fund Advisers, LLC holds 1,178 shares of AMPH stock, worth $53,257. This represents 0.28% of its overall portfolio holdings.

Number of Shares
1,178
Previous 1,178 -0.0%
Holding current value
$53,257
Previous $47,000 21.28%
% of portfolio
0.28%
Previous 0.19%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$38.65 - $43.48 $3,401 - $3,826
88 Added 8.07%
1,178 $47,000
Q1 2024

May 15, 2024

BUY
$42.85 - $63.45 $4,670 - $6,916
109 Added 11.11%
1,090 $47,000
Q2 2023

Aug 14, 2023

BUY
$35.77 - $58.38 $35,090 - $57,270
981 New
981 $56,000

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $2.22B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Virtus Fund Advisers, LLC Portfolio

Follow Virtus Fund Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus Fund Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus Fund Advisers, LLC with notifications on news.